Does a local bystander effect necessitate a revision of TCP models that are based on observed clinical data?

Acta Oncologica

Volumn 45, Issue 4, 2006, Pages 406-411

  Tomé, Wolfgang ^a,c   Fenwick, John ^b   Bentzen, Søren ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

^c K4/344 CSC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; BYSTANDER EFFECT; CANCER CELL; CANCER CONTROL; CLINICAL RESEARCH; CLINICAL STUDY; DATA ANALYSIS; MATHEMATICAL MODEL; MICROSCOPY; PRIORITY JOURNAL; PROBABILITY; TUMOR CONTROL PROBABILITY;

BYSTANDER EFFECT; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; NEOPLASMS; PROBABILITY;

EID: 33745104414     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860500468935     Document Type: Article

References (35)

1. Prise KM, Belyakov OV, Folkard M, Micheal BD. Studies of bystander effect in human fibroblasts using a charged particle microbeam. Int J Radiat Biol 1998;74:793-8.
2. Randers-Pehrson G, Geard CR, Johnson CD, Elliston CD, Brenner DJ. The Columbia University single-ion microbeam. Radiat Res 2001;156:210-4.
3. Hall EJ. The bystander effect. Health Physics 2003;85:31-5.
4. Hall EJ, Hei TK. Genomic instability and bystander effects induced by high-LET radiation. Oncogene 2003;22:7034-42.
5. Schettino G, Folkard M, Prise KM, Vojnovic B, Held KD, Michael BD. Low-dose studies of bystander cell killing with targeted soft X-Rays. Radiat Res 2003;160:505-11.
6. Mothersill C, Seymour CB. Radiation-induced bystander effects: Past history and future directions. Radiat Res 2001;155:759-67.
7. Belyakov OV, Mitchel SA, Parikh D, Randers-Pehrson, Marino S, Amundson SA, et al. Biological effects in unirradiated human tissue induced by radiation damage up to 1 mm away. Proc Natl Acad 2005;102:14203-8.
8. Mothersill C, O'Malley K, Seymour CB. Characterization of a bystander effect induced in human tissue explant cultures by low LET radiation. Radiat Prot Dosimetry 2002;99:163-7.
9. Prise KM, Schettino G, Folkard M, Held D. New insights on cell death from radiation exposure. Lancet Oncol 2005;6(7):520-8.
10. Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol 1984;23:379-91.
11. Bentzen SM, Thames HD. Tumor volume and local control probability: Clinical and radiobiological interpretations. Int J Radiat Oncol Biol Phys 1996;36:247-51.
12. Goitein M. The probability of controlling an inhomogeneously irradiated tumor. In: Zink S, editor. Report of the working group on the evaluation of treatment planning for particle beam radiotherapy. Bethesda, Maryland, USA: National Cancer Institute; 1987.
13. th LH Gray Conference. London: Br Inst Radiol; 1995. p. 25-32.
14. Fenwick JD. Predicting the radiation control probability of heterogeneous tumor ensembles: Data analysis and parameter estimation using a closed-form expression. Phys Med Biol 1998;43:2159-78.
15. Nahum AE, Tait DM. Maximizing local control by customized dose prescription for pelvic tumours. In: Breit A, editor. Adv. Radiation Therapy Response Monitoring and Treatment Planning. Berlin: Springer; 1992. p. 425-31.
16. Niemierko A, Goitein M. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother Oncol 1993;29:140-7.
17. Suit H, Skates S, Taghain A, Okunieff P, Efird JT. Clinical implications of heterogeneity of tumor response to radiation therapy. Radiother Oncol 1992;25:251-60.
18. Webb S, Nahum AE. The biological effect of inhomogeneous tumor irradiation with inhomogeneous clonogenic cell density. Phys Med Biol 1993;38:653-66.
19. Zagras GK, Shultheiss TE, Peters LJ. Inter-tumour heterogeneity and radiation dose control curves. Radiother Oncol 1987;8:353-62.
20. Munro TR, Gilbert CW. The relation between tumour lethal doses and the radiosensitivity of tumour cells. Br J Radiol 1961;34:246-51.
21. Lindley DV. Introduction to Probability and Statistics: From a Bayesian Viewpoint Part 1, Probability. London: Cambridge University Press; 1965.
22. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-46.
23. Roberts SA, Hendry JH. Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centres. Int J Radiat Oncol Biol Phys 1999;45:1247-57.
24. Withers HR, Thames HD, Peters LJ. A new isoeffect curve for change in dose per fraction. Radiother Oncol 1983;2:187-91.
25. Fowler JF. The first James Kirk memorial lecture. What is next in fractionated radiotherapy? Br J Cancer Supp 1984;6:285-300.
26. Bentzen SM. Steepness of the clinical dose-control curve and variation in the in-vitro radio-sensitivity of head and neck squamous cell carcinoma. Int J Radiat Biol 1992;62:417-23.
27. Brenner JD. Dose, volume and tumor-control predictions in radiotherapy. Int J Radiat Oncol Biol Phys 1993;26:171-9.
28. Roberts SA, Hendry JH. A realistic closed-form radiobiological model of clinical tumor-control data incorporating inter-tumor heterogeneity. Int J Radiat Oncol Biol Phys 1998;41:689-99.
29. Suwinski R, Taylor JMG, Withers HR. The effect of heterogeneity in tumor cell kinetics on radiation dose-response. An exploratory investigation of a plateau effect. Int J Radiat Oncol Biol Phys 1999;50:57-66.
30. Bentzen SM, Thames HD, Overgaard J. Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for maligmant melanoma. Int J Radiat Biol 1990;57:117-26.
31. Buffa FM, Davidson SE, Hunter D, Nahum AE, West CML. Incorporating biological measurements (SF2, CFE) in a tumor control probability model increases their prognostic significance: A study in cervical carcinoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 2001;50:1113-22.
32. Tomé WA, Fowler JF. On the inclusion of the proliferation term into tumour control probability calculations for inhomogeneously irradiated tumours. Phys Med Biol 2003;48:N261-8.
33. Tomé WA, Fowler JF. On cold spots in tumor subvolumes. Med Phys 2002;29:1590-8.
34. Tomé WA, Meeks SL, Buatti LM, Bova FJ, Friedman WA, Li Z. A high precision system for conformal intracranial radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1137-43.
35. Tomé WA, Meeks SL, McNutt TR, Buatti JM, Bova FJ, Friedman WA, et al. Optically guided intensity modulated radiotherapy. Radiotherapy Oncol 2001;61:33-44.